Impact of Quadruple Regimen of Clarithromycin Added to Metronidazole‐Containing Triple Therapy Against<i>Helicobacter pylori</i>Infection Following Clarithromycin‐Containing Triple‐Therapy Failure

Abstract

In Japan, the RAMC regimen is thought to be a promising alternative strategy for second-line eradication of H. pylori infection.